Terms: = Testicular cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Treatment
12 results:
1. Genomic landscape and distinct molecular subtypes of primary testicular lymphoma.
Zhang W; Yang P; Yang Y; Liu S; Xu Y; Wu C; Wang J; Liu C; Liu H; Li S; Huang W; Jing H
J Transl Med; 2024 May; 22(1):414. PubMed ID: 38693538
[TBL] [Abstract] [Full Text] [Related]
2. Adult granulosa cell tumor of the testis with malignant tendency: A case report with genetic analysis using high-throughput sequencing.
Deng L; Zeng J; Qiu JF; Yang LH; Ma J
Medicine (Baltimore); 2023 Aug; 102(32):e34523. PubMed ID: 37565864
[TBL] [Abstract] [Full Text] [Related]
3. Extrinsic apoptosis and senescence involved in growth kinetics of seminoma to cisplatin.
Yin Y; Peng J; Zheng X; Zhou J; Wang Y; Dai Y; Yin G; Tang Y
Clin Exp Pharmacol Physiol; 2023 Feb; 50(2):140-148. PubMed ID: 36222180
[TBL] [Abstract] [Full Text] [Related]
4. Immunosenescence profile and expression of the aging biomarker (p16
Bourlon MT; Velazquez HE; Hinojosa J; Orozco L; Rios-Corzo R; Lima G; Llorente L; Hernandez-Ramirez DF; Valentin-Cortez FJ; Medina-Rangel I; Atisha-Fregoso Y
BMC Cancer; 2020 Sep; 20(1):882. PubMed ID: 32928147
[TBL] [Abstract] [Full Text] [Related]
5. Targetable genetic features of primary testicular and primary central nervous system lymphomas.
Chapuy B; Roemer MG; Stewart C; Tan Y; Abo RP; Zhang L; Dunford AJ; Meredith DM; Thorner AR; Jordanova ES; Liu G; Feuerhake F; Ducar MD; Illerhaus G; Gusenleitner D; Linden EA; Sun HH; Homer H; Aono M; Pinkus GS; Ligon AH; Ligon KL; Ferry JA; Freeman GJ; van Hummelen P; Golub TR; Getz G; Rodig SJ; de Jong D; Monti S; Shipp MA
Blood; 2016 Feb; 127(7):869-81. PubMed ID: 26702065
[TBL] [Abstract] [Full Text] [Related]
6. Direct estradiol and diethylstilbestrol actions on early- versus late-stage prostate cancer cells.
Koong LY; Watson CS
Prostate; 2014 Dec; 74(16):1589-603. PubMed ID: 25213831
[TBL] [Abstract] [Full Text] [Related]
7. CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer.
Ellinger J; Albers P; Perabo FG; Müller SC; von Ruecker A; Bastian PJ
J Urol; 2009 Jul; 182(1):324-9. PubMed ID: 19447423
[TBL] [Abstract] [Full Text] [Related]
8. Expression of CD117 (c-kit) receptor in dysgerminoma of the ovary: diagnostic and therapeutic implications.
Sever M; Jones TD; Roth LM; Karim FW; Zheng W; Michael H; Hattab EM; Emerson RE; Baldridge LA; Cheng L
Mod Pathol; 2005 Nov; 18(11):1411-6. PubMed ID: 16056250
[TBL] [Abstract] [Full Text] [Related]
9. Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications.
Donahoe PK; Clarke T; Teixeira J; Maheswaran S; MacLaughlin DT
Mol Cell Endocrinol; 2003 Dec; 211(1-2):37-42. PubMed ID: 14656474
[TBL] [Abstract] [Full Text] [Related]
10. The attractive Achilles heel of germ cell tumours: an inherent sensitivity to apoptosis-inducing stimuli.
Spierings DC; de Vries EG; Vellenga E; de Jong S
J Pathol; 2003 Jun; 200(2):137-48. PubMed ID: 12754734
[TBL] [Abstract] [Full Text] [Related]
11. Mullerian inhibiting substance inhibits ovarian cell growth through an Rb-independent mechanism.
Ha TU; Segev DL; Barbie D; Masiakos PT; Tran TT; Dombkowski D; Glander M; Clarke TR; Lorenzo HK; Donahoe PK; Maheswaran S
J Biol Chem; 2000 Nov; 275(47):37101-9. PubMed ID: 10958795
[TBL] [Abstract] [Full Text] [Related]
12. Phase I clinical and pharmacokinetic study of high-dose mitoxantrone combined with carboplatin, cyclophosphamide, and autologous bone marrow rescue: high response rate for refractory ovarian carcinoma.
Stiff PJ; McKenzie RS; Alberts DS; Sosman JA; Dolan JR; Rad N; McCloskey T
J Clin Oncol; 1994 Jan; 12(1):176-83. PubMed ID: 8270975
[TBL] [Abstract] [Full Text] [Related]
